| Primary |
| Product Used For Unknown Indication |
53.8% |
| Hypersensitivity |
11.5% |
| Drug Use For Unknown Indication |
7.7% |
| Rhinorrhoea |
7.7% |
| Seasonal Allergy |
7.7% |
| Cough |
3.8% |
| Medical Observation |
3.8% |
| Mycotic Allergy |
3.8% |
|
| Drug Ineffective |
20.0% |
| Somnolence |
10.0% |
| Drug Effect Decreased |
5.0% |
| Faeces Discoloured |
5.0% |
| Haematochezia |
5.0% |
| Inappropriate Schedule Of Drug Administration |
5.0% |
| Leukaemia |
5.0% |
| Muscular Weakness |
5.0% |
| Oral Discomfort |
5.0% |
| Overdose |
5.0% |
| Pain In Extremity |
5.0% |
| Prostatomegaly |
5.0% |
| Sleep Disorder |
5.0% |
| Visual Disturbance |
5.0% |
| Visual Impairment |
5.0% |
| White Blood Cell Morphology Abnormal |
5.0% |
|
| Secondary |
| Chemotherapy |
57.1% |
| Product Used For Unknown Indication |
26.2% |
| Tongue Neoplasm Malignant Stage Unspecified |
7.1% |
| Prophylaxis |
4.8% |
| Medical Observation |
2.4% |
| Mycotic Allergy |
2.4% |
|
| Bone Pain |
25.0% |
| Pain In Extremity |
25.0% |
| Acute Sinusitis |
12.5% |
| Inappropriate Schedule Of Drug Administration |
12.5% |
| Neutropenia |
12.5% |
| Vomiting |
12.5% |
|
| Concomitant |
| Prophylaxis |
15.7% |
| Drug Use For Unknown Indication |
15.4% |
| Premedication |
10.1% |
| Product Used For Unknown Indication |
9.4% |
| Transfusion |
7.5% |
| Allergy Prophylaxis |
6.6% |
| Colon Cancer |
3.7% |
| Rectal Cancer |
3.3% |
| Pain |
3.0% |
| Infection |
2.9% |
| Fluid Replacement |
2.8% |
| Renal Cell Carcinoma |
2.8% |
| Asthma |
2.3% |
| Hypertension |
2.3% |
| Chemotherapy |
2.2% |
| Hypersensitivity |
2.2% |
| Colorectal Cancer |
2.2% |
| Sedation |
1.9% |
| Infection Prophylaxis |
1.8% |
| Neoplasm Malignant |
1.8% |
|
| White Blood Cell Count Decreased |
13.0% |
| Renal Cell Carcinoma |
10.6% |
| Interstitial Lung Disease |
8.2% |
| Stomatitis |
8.2% |
| Restlessness |
7.2% |
| Febrile Neutropenia |
4.3% |
| Insomnia |
4.3% |
| Death |
3.8% |
| Dyspnoea |
3.8% |
| Rash |
3.8% |
| Ventricular Septal Defect |
3.8% |
| Drug Ineffective |
3.4% |
| Hepatic Failure |
3.4% |
| Infusion Related Reaction |
3.4% |
| Ovarian Cancer |
3.4% |
| Tremor |
3.4% |
| Weight Decreased |
3.4% |
| Colorectal Cancer |
2.9% |
| Coronary Artery Disease |
2.9% |
| Platelet Count Decreased |
2.9% |
|
